![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/145 |
(11) | Number of the document | 2493501 |
(13) | Kind of document | T |
(96) | European patent application number | 10768502.6 |
Date of filing the European patent application | 2010-10-25 | |
(97) | Date of publication of the European application | 2012-09-05 |
(45) | Date of publication and mention of the grant of the patent | 2017-04-05 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2010/066083 |
Date | 2010-10-25 |
(87) | Number | WO 2011/051235 |
Date | 2011-05-05 |
(30) | Number | Date | Country code |
0918830 | 2009-10-27 | GB | |
329230 P | 2010-04-29 | US |
(72) |
D` HONDT, Erik Jozef, BE
ENGELMANN, Hans Bernd, DE
|
(73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
GlaxoSmithKline Biologicals, Niederlassung der SmithKline Beecham Pharma GmbH & Co. KG, Zirkusstrasse 40, 01069 Dresden, DE |
(54) | PROCESS FOR PRODUCING INFLUENZA VACCINE |
PROCESS FOR PRODUCING INFLUENZA VACCINE |